XNYS
CC
Market cap2.62bUSD
Jul 09, Last price
17.39USD
1D
-5.39%
1Q
-23.43%
Jan 2017
-21.28%
IPO
5.33%
Name
Chemours Co
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
The Chemours Company, established in Wilmington, Delaware in 2014, is a global purveyor of high-performance chemicals, serving clients across North America, the Asia Pacific region, Europe, the Middle East, Africa, and Latin America. Its operations are structured into four principal divisions. The Titanium Technologies segment specializes in titanium dioxide pigments, marketed under the Ti-Pure and BaiMax brands, which impart critical properties like brightness, opacity, and protective qualities for diverse applications such as architectural and industrial paints, flexible and rigid plastic packaging, PVC products, laminate materials for furniture and construction, and coated papers for packaging. The Thermal & Specialized Solutions division provides a range of products including refrigerants, thermal management systems, propellants, foam expansion agents, and specialized solvents. The Advanced Performance Materials sector offers an array of industrial resins, bespoke products, membranes, and protective coatings, which are crucial for industries spanning consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical technologies. Lastly, the Chemical Solutions segment supplies industrial chemicals, functioning as raw materials and catalysts for various processes including gold extraction, cleaning and disinfection, oil and gas operations, water treatment, electronics manufacturing, and automotive applications. The company facilitates sales through both direct and indirect channels, alongside a comprehensive network of resellers and distributors.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||